(주)셀렉스라이프사이언스

News

ILIAS is the Leader of Next-Generation Exosome Therapeutics.

[ENG] 보도자료

ILIAS Biologics, challenges the undruggable with its unique Exosome platform technology

페이지 정보

  • 작성자 : ILIAS Biologics
  • 작성일 : 20-12-09 09:20
  • 조회 : 131회

본문

 

7 Dec 2020


ILIAS Biologics, challenges the undruggable with its unique Exosome platform technology  

 

BioSpectator, a leading biopharma contents provider, has featured ILIAS biologics focusing on our major scientific achievements of the two recent research papers (doi.org/10.1016/j.ajog.2019.06.010, doi:10.1126/sciadv.aaz6980) and EXPLOR® (doi: 10.1038/ncomms12277) on its on-line news platform. This in-depth feature article introduced ILIAS biologics as the pioneer with the original platform technology of Exosome.    

 

Please find the link below for more information.

(Kor)


개인정보취급방침

닫기

이메일주소무단수집거부

닫기

사이트맵

사이트맵

몬트리올의정서
국내이행법령
사업안내
특정물질 수출입
알림·자료실
민원서비스
닫기